首页> 美国政府科技报告 >In vitro and In vivo Studies for Development of a Leishmaniasis Vaccine
【24h】

In vitro and In vivo Studies for Development of a Leishmaniasis Vaccine

机译:体外和体内研究开发利什曼病疫苗

获取原文

摘要

The goal of this contract is to identify, characterize , and test antigens of Leishmania that could serve as candidate vaccines against cutaneous leishmaniasis. We successfully purified monoclonal antibodies from ascites by a protein G affinity chromatography method. These were employed to characterize antigens recognized by the monoclonal antibodies with Western blot methods. Attempts to assess whether the monoclonal antibodies were directed to carbohydrate moieties could not be undertaken since we found that antibodies nonspecifically adsorbed metabolically-labeled antigens. Using a radioimmunoassay that we developed, we attempted to detect leishmanial antigens expressed on the surface of P388D1 cells infected with L. major. Keywords: Promastigotes; Macrophages; Antileishmanial drugs. (AW)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号